Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

2.

Inhibition of pancreatic adenocarcinoma cell growth by lovastatin.

Sumi S, Beauchamp RD, Townsend CM Jr, Uchida T, Murakami M, Rajaraman S, Ishizuka J, Thompson JC.

Gastroenterology. 1992 Sep;103(3):982-9.

PMID:
1499946
4.

Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Roelofs AJ, Edwards CM, Russell RG, Ebetino FH, Rogers MJ, Hulley PA.

J Pharmacol Exp Ther. 2007 Jul;322(1):228-35. Epub 2007 Apr 5.

5.
6.

Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.

Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freedman MH, Yeger H, Penn LZ.

Clin Cancer Res. 2001 Jan;7(1):158-67.

7.

Antitumor effects of the combination of cholesterol reducing drugs.

Issat T, Nowis D, Bil J, Winiarska M, Jakobisiak M, Golab J.

Oncol Rep. 2011 Jul;26(1):169-76. doi: 10.3892/or.2011.1261. Epub 2011 Apr 13.

PMID:
21491092
8.

Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines.

Wang W, Macaulay RJ.

Can J Neurol Sci. 1999 Nov;26(4):305-10.

PMID:
10563217
9.
10.

Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway.

Dimitroulakos J, Lorimer IA, Goss G.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4426s-4431s. Review.

11.
13.

Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.

Choi JW, Jung SE.

J Pharmacol Exp Ther. 1999 Apr;289(1):572-9.

14.

d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.

Hussein D, Mo H.

Pancreas. 2009 May;38(4):e124-36. doi: 10.1097/MPA.0b013e3181a20f9c.

PMID:
19346993
15.
16.
17.

In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent.

Maksimova E, Yie TA, Rom WN.

Lung. 2008 Jan-Feb;186(1):45-54. Epub 2007 Nov 22.

PMID:
18034278
18.

Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.

Rybak SM, Pearson JW, Fogler WE, Volker K, Spence SE, Newton DL, Mikulski SM, Ardelt W, Riggs CW, Kung HF, Longo DL.

J Natl Cancer Inst. 1996 Jun 5;88(11):747-53.

19.

Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by onconase.

Halicka HD, Murakami T, Papageorgio CN, Mittelman A, Mikulski SM, Shogen K, Darzynkiewicz Z.

Cell Prolif. 2000 Dec;33(6):407-17.

PMID:
11101012
20.

Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.

McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H.

Exp Biol Med (Maywood). 2007 Apr;232(4):523-31.

PMID:
17392488
Items per page

Supplemental Content

Write to the Help Desk